STOCK TITAN

Barrick Mining Corporation Stock Price, News & Analysis

B NYSE

Welcome to our dedicated page for Barrick Mining Corporation news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining Corporation stock.

Barnes Group Inc. (NYSE: B) maintains its position as a global leader in precision industrial technologies and aerospace solutions. This news hub provides investors and industry professionals with essential updates on corporate developments, financial performance, and strategic initiatives.

Access timely updates spanning earnings announcements, product innovations, and operational milestones. Our curated collection features official press releases alongside market analysis relevant to Barnes Grp's industrial and aerospace segments.

Key coverage areas include manufacturing advancements in transportation systems, aerospace component developments, and strategic partnerships across global markets. The repository serves as a reliable resource for understanding the company's impact on sectors ranging from healthcare infrastructure to defense technologies.

Bookmark this page for streamlined access to Barnes Grp's latest financial disclosures and operational updates. Regularly refreshed content ensures stakeholders maintain current awareness of this engineering leader's market position and technological contributions.

Rhea-AI Summary

Barrick Mining (NYSE:B) hosted its Annual Sustainability Update and released its Summary Sustainability Report, highlighting six years of sustainability achievements since its transformative merger. The company has distributed over $70 billion to various stakeholders including workers, local businesses, community projects, and governments.

Under CEO Mark Bristow's leadership, Barrick's sustainability initiatives focus on UN Sustainable Development Goals, workplace safety, and greenhouse gas emissions management. The company has made significant progress in transitioning to renewable energy sources and has invested in community infrastructure including schools, health clinics, and water access facilities.

The new Summary Sustainability Report complements the comprehensive 2024 Sustainability Report, offering stakeholders a more accessible overview of the company's global environmental and social impact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none
-
Rhea-AI Summary

Crawford & Company (NYSE: CRD-A and CRD-B) announced an increase in its quarterly dividend. The Board of Directors approved a quarterly dividend of $0.075 per share for both Class A and Class B Common Stock, representing a $0.005 increase from the previous quarter.

The dividend will be paid on August 29, 2025, to shareholders of record as of August 15, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
dividends
-
Rhea-AI Summary

BioArctic AB (Nasdaq Stockholm: BIOA B) reported that its partner Eisai achieved Leqembi® sales of JPY 23.1 billion in Q2 2025. This generated royalty revenue of SEK 162.5 million for BioArctic, representing a 280% increase compared to Q2 2024.

The quarter's sales included a one-time stockpiling effect of JPY 5.3 billion in the Chinese market due to tariff risks. Excluding this effect, global sales were JPY 17.8 billion, corresponding to royalty revenue of approximately SEK 125 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
Rhea-AI Summary

BioArctic AB (NASDAQ Stockholm: BIOA B) and partner Eisai presented compelling new data for lecanemab (Leqembi®) at AAIC 2025, showcasing significant treatment benefits over four years. The data demonstrated that lecanemab slows disease progression by approximately one year compared to no treatment over a four-year period.

Key findings include: 69% of early-stage patients showed improvement or no decline after four years of treatment, an 84% stability or improvement rate in real-world studies, and promising results for a new subcutaneous administration option. The safety profile remained consistent with previous studies, with decreased ARIA rates after initial 12 months.

The real-world study revealed high retention rates of 87%, with 20% of long-term patients improving from mild Alzheimer's to MCI. The new subcutaneous autoinjector showed comparable efficacy to IV administration while offering more convenient at-home treatment options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
none
-
Rhea-AI Summary

ETQ, a subsidiary of Hexagon (HEXA), reported significant growth milestones in Q2 2025, expanding its customer base across multiple sectors including heavy industry, life sciences, and manufacturing. The company launched an enhanced version of its ETQ Reliance NXG® quality management system, featuring a new Quality Data Lake powered by Snowflake.

Key developments include new customer acquisitions such as AALTO HAPS and W.L. Gore, alongside expanded deployments with existing clients like A.O. Smith and Medline Industries. The company's annual quality survey revealed a strategic shift in manufacturing, with quality becoming a key driver of revenue growth. Additionally, ETQ will be part of Hexagon's planned spin-off 'Octave', expected to be completed in H1 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.86%
Tags
none
-
Rhea-AI Summary

BioArctic AB (Nasdaq Stockholm: BIOA B) announced that its partner Eisai will present significant new data on Leqembi® (lecanemab) at the upcoming Alzheimer's Association International Conference (AAIC) in Toronto from July 27-31, 2025.

Key presentations include four-year efficacy and safety data from the Phase 3 Clarity AD Open-Label Extension trial, new data on a subcutaneous formulation for maintenance dosing, and real-world case studies from U.S. clinical settings. Additionally, findings from cerebrospinal fluid samples using a novel immunoassay for measuring Aβ protofibrils will be presented.

Eisai leads the global development and regulatory submissions for Leqembi, with both Eisai and Biogen co-commercializing the product. BioArctic maintains commercialization rights in the Nordic region in partnership with Eisai.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
none
Rhea-AI Summary

Hexagon (HEXA) and Management Controls Inc. (MCi) have officially launched their integrated EcoSys + myTrack solution, combining Hexagon's EcoSys platform with MCi's myTrack platform. The integration aims to transform the management of shutdowns, turnarounds, and outages (STO) and capital projects.

The solution provides real-time cost and progress visibility by automating the collection and validation of contractor labor, equipment, and material data from the field. Key features include daily actuals tracking, SPI/CPI metrics within hours of shift completion, real-time vendor performance monitoring, and full alignment across scheduling and ERP systems.

The integrated solution, developed with FTI Consulting's implementation expertise, was initially unveiled at Hexagon LIVE Global 2025 in Las Vegas, targeting industries such as energy, chemicals, construction, and manufacturing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
crypto
-
Rhea-AI Summary

Barrick Mining Corporation (NYSE:B) has announced it will release its Q2 2025 financial results on Monday, August 11, 2025, before market open at approximately 6:00 AM EDT. The company's President and CEO Mark Bristow will host a live presentation and webcast at 11:00 AM EDT, which will include a Q&A session with analysts.

The presentation materials will be accessible on Barrick's website, and the webinar recording will be available for later viewing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
conferences earnings
-
Rhea-AI Summary

BioArctic AB (Nasdaq Stockholm: BIOA B) announced that its partner Eisai has received the 9th Bioindustry Award from the Japan Bioindustry Association for the drug discovery research of lecanemab (Leqembi®), an antibody treatment for early Alzheimer's disease.

The treatment, co-developed by BioArctic and Eisai, is based on Professor Lars Lannfelt's discoveries about amyloid-beta protein's role in Alzheimer's disease. Lecanemab works by binding to specific forms of amyloid-beta and helping clear it from the brain. Eisai leads the global development and regulatory submissions, with both Eisai and Biogen handling commercialization. BioArctic retains commercialization rights in the Nordic region in partnership with Eisai.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
none
Rhea-AI Summary

Hexagon US Federal (HEXA) has announced the divestiture of its Strategic Services & Solutions (HS3) business to Bart & Associates (B&A), as initially disclosed on July 2, 2025. This strategic move aims to streamline operations and sharpen focus on the company's core technology offerings.

The company will concentrate on delivering cutting-edge software, hardware, and value-added products supporting defense, intelligence, and federal-civilian missions across public safety, geospatial-intelligence, sensors & systems, and position, navigation, and timing (PNT). The HS3 business, known for providing IT services, geospatial services, and integrated solutions, will continue its federal government support under B&A's ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
none

FAQ

What is the current stock price of Barrick Mining Corporation (B)?

The current stock price of Barrick Mining Corporation (B) is $32.99 as of September 19, 2025.

What is the market cap of Barrick Mining Corporation (B)?

The market cap of Barrick Mining Corporation (B) is approximately 51.3B.
Barrick Mining Corporation

NYSE:B

B Rankings

B Stock Data

51.30B
1.69B
0.8%
62.71%
1.58%
Gold
Miscellaneous Fabricated Metal Products
Link
Canada
BRISTOL